Correlation Between Loncar Cancer and Direxion Work

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Loncar Cancer and Direxion Work at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Loncar Cancer and Direxion Work into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Loncar Cancer Immunotherapy and Direxion Work From, you can compare the effects of market volatilities on Loncar Cancer and Direxion Work and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Loncar Cancer with a short position of Direxion Work. Check out your portfolio center. Please also check ongoing floating volatility patterns of Loncar Cancer and Direxion Work.

Diversification Opportunities for Loncar Cancer and Direxion Work

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Loncar and Direxion is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Loncar Cancer Immunotherapy and Direxion Work From in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Direxion Work From and Loncar Cancer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Loncar Cancer Immunotherapy are associated (or correlated) with Direxion Work. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Direxion Work From has no effect on the direction of Loncar Cancer i.e., Loncar Cancer and Direxion Work go up and down completely randomly.

Pair Corralation between Loncar Cancer and Direxion Work

Given the investment horizon of 90 days Loncar Cancer is expected to generate 104.54 times less return on investment than Direxion Work. In addition to that, Loncar Cancer is 2.08 times more volatile than Direxion Work From. It trades about 0.0 of its total potential returns per unit of risk. Direxion Work From is currently generating about 0.25 per unit of volatility. If you would invest  5,531  in Direxion Work From on September 2, 2024 and sell it today you would earn a total of  941.00  from holding Direxion Work From or generate 17.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Loncar Cancer Immunotherapy  vs.  Direxion Work From

 Performance 
       Timeline  
Loncar Cancer Immuno 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Loncar Cancer Immunotherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Loncar Cancer is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Direxion Work From 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Direxion Work From are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating technical and fundamental indicators, Direxion Work demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Loncar Cancer and Direxion Work Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Loncar Cancer and Direxion Work

The main advantage of trading using opposite Loncar Cancer and Direxion Work positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Loncar Cancer position performs unexpectedly, Direxion Work can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Direxion Work will offset losses from the drop in Direxion Work's long position.
The idea behind Loncar Cancer Immunotherapy and Direxion Work From pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments